Use or non-use of treatment therapies for swine respiratory disease in finishing pigsUse or non-use of treatment therapies for swine respiratory disease in finishing pigs

Dr. David Baumert of Zoetis discusses the reasons why producers sometimes choose not to treat pigs — usually heavier weight finishers — in need of swine respiratory disease (SRD) therapy and the implications of non-use from a performance, labor and economic standpoint.

Sponsorship Language: Brought to you by Zoetis Pork

¹Pantoja L, Kuhn M, Farrand E, et al. Impact of a Husbandry Education Program on nursery pig mortality, productivity, and treatment cost. Journal of Swine Health and Production [serial online]. 2013;21 (4):188-194. Available from: CAB Abstracts, Ipswich, MA. Accessed May 1, 2018.

²Pineiro C, Morales J, Doncecchi P, et al. Individual Pig Care program improves productive performance and animal health in nursery-growing pigs. Journal of Swine Health and Production [serial online]. 2014;22 (6):296-299. Available from: CAB Abstracts, Ipswich, MA. Accessed August 1, 2018.

³Bowersock, T. L., Meeuwse, D. M., Kausche, F. M., Lucas, M. J., Bryson, W. L. and Dame, K.J. Efficacy of ceftiofur crystalline free acid and ceftiofur hydrochloride administered intramuscularly in swine inoculated with Actinobacillus pleuropneumoniae. Pharmacia Animal Health. 2001.

⁴Data on file, Study Document No. ZRD-PSC-004402, Zoetis Inc.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. © 2024 Zoetis Services LLC. All rights reserved. EXC-00082

Related:Novus, Resilient Biotics partner on new swine health solution